- Home
- GO vs IMCR Comparison
GO vs IMCR Comparison
Compare GO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GO
- IMCR
- Stock Information
- Founded
- GO 1946
- IMCR 2008
- Country
- GO United States
- IMCR United Kingdom
- Employees
- GO N/A
- IMCR N/A
- Industry
- GO Food Chains
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GO Consumer Staples
- IMCR Health Care
- Exchange
- GO Nasdaq
- IMCR Nasdaq
- Market Cap
- GO 1.6B
- IMCR 1.7B
- IPO Year
- GO 2019
- IMCR 2021
- Fundamental
- Price
- GO $18.65
- IMCR $32.12
- Analyst Decision
- GO Hold
- IMCR Buy
- Analyst Count
- GO 11
- IMCR 13
- Target Price
- GO $18.00
- IMCR $68.73
- AVG Volume (30 Days)
- GO 2.7M
- IMCR 237.7K
- Earning Date
- GO 11-05-2024
- IMCR 11-06-2024
- Dividend Yield
- GO N/A
- IMCR N/A
- EPS Growth
- GO N/A
- IMCR N/A
- EPS
- GO 0.51
- IMCR N/A
- Revenue
- GO $4,263,465,000.00
- IMCR $296,312,000.00
- Revenue This Year
- GO $13.11
- IMCR $28.88
- Revenue Next Year
- GO $8.53
- IMCR $12.61
- P/E Ratio
- GO $36.54
- IMCR N/A
- Revenue Growth
- GO 9.03
- IMCR 25.09
- 52 Week Low
- GO $13.60
- IMCR $29.72
- 52 Week High
- GO $29.80
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- GO 60.10
- IMCR 46.91
- Support Level
- GO $17.52
- IMCR $30.52
- Resistance Level
- GO $18.79
- IMCR $33.61
- Average True Range (ATR)
- GO 0.92
- IMCR 1.68
- MACD
- GO 0.19
- IMCR -0.14
- Stochastic Oscillator
- GO 83.65
- IMCR 39.00
About GO Grocery Outlet Holding Corp.
Grocery Outlet Holding Corp is a grocery store operator in the United States. Its flexible buying model allows them to offer quality, name-brand opportunistic products at prices generally 40% to 70% below those of conventional retailers. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.